Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NQO1 modulators(Quinone reductase 1 modulators), p53 stimulants(Tumor protein p53 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | CN | 25 May 2021 |